載入...
Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR
BACKGROUND: Patients with metastatic colorectal cancer can benefit from anti-EGFR therapy, such as cetuximab and panitumumab. However, colorectal cancers harboring constitutive activating mutations in KRAS, NRAS and BRAF genes are not responsive to anti-EGFR therapy. To select patients for appropria...
Na minha lista:
| 發表在: | BMC Med Genomics |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849194/ https://ncbi.nlm.nih.gov/pubmed/31711486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-019-0610-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|